Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The importance of studying the genetic landscape of myeloid malignancies

Enrico Attardi • 10 Jun 2022
EHA 2022
Myelodysplastic Syndromes Danazol Lenalidomide

Enrico Attardi, MD, University of Rome Tor Vergata, Rome Italy, discusses the clinical implications related to the identification of inherited predisposition to myeloid malignancies such as myelodysplastic syndromes (MDS). Knowledge of these germline variants can be used for genetic counseling, but also to help understand the biology of the disease, and to personalize treatment. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from Enrico Attardi

3:13
Validation of 2022 diagnostic & prognostic classifications of AML
Enrico Attardi • 21 Mar 2023
3:20
Comparing the ICC and WHO classifications for secondary AML and their impact on clinical practice
Enrico Attardi • 21 Mar 2023
3:01
The role of PIEZ01 variants in patients with MDS
Enrico Attardi • 10 Jun 2022
3:11
Clinical characteristics of h-MDS
Enrico Attardi • 10 Jun 2022

Related Videos

2:22
Haplo-SCT for older patients with AML/MDS, and should age be a barrier to transplantation?
Raynier Devillier • 15 Apr 2024
2:31
Emerging treatment options for patients with ESA-refractory MDS: luspatercept & imetelstat
Eva Hellström-Lindberg • 11 Apr 2024
1:49
The unmet needs of patients with VEXAS syndrome
Maël Heiblig • 17 Apr 2024
1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
The content of VJHemOnc is intended for healthcare professionals